Cellectar Biosciences, Inc.
CLRBW
CLRBW was delisted on the 20th of August, 2019.
3 hedge funds and large institutions have $8K invested in Cellectar Biosciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
77% less capital invested
Capital invested by funds: $35K → $8K (-$27K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$23K |
CLRBW Hedge Fund Activity: Q3 2017 in Review
3 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q3 2017, worth a combined $8K — down 77% from $35K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CLRBW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was AWM Investment Company, exiting entirely with an estimated $23K sold.
- 3 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q3 2017, down from 4 in Q2 2017.
- Funds reported $8K of Cellectar Biosciences, Inc. stock for Q3 2017, down 77% quarter-over-quarter.
- 0 funds opened new Cellectar Biosciences, Inc. positions in Q3 2017 and 1 closed out, a net change of -1 holder.
- The largest Cellectar Biosciences, Inc. seller in Q3 2017 was AWM Investment Company, an estimated $23K sold.
Based on aggregated 13F filings for Q3 2017.